An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
DexCom, Inc. (NASDAQ:DXCM) will release its third quarter 2022 financial results on October 27, 2022, after market close.
A conference call is scheduled for 4:30 p.m. (Eastern Time) on the same day to review performance, with a webcast available on their investor relations website.
Investors can call in at (866) 374-5140 (US/Canada) or (404) 400-0571 (International) using confirmation number 56107665#.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company's third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (866) 374-5140 (US/Canada) or (404) 400-0571 (International) and use the confirmation number "56107665#" approximately five minutes prior to the start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
DexCom, Inc.:
Sean Christensen Vice President – Finance and Investor Relations
investor-relations@dexcom.com
(858) 200-0200
Source: DexCom, Inc.
FAQ
When will DexCom release its Q3 2022 financial results?
DexCom will release its Q3 2022 financial results on October 27, 2022, after market close.
What time is the DexCom Q3 2022 conference call?
The DexCom Q3 2022 conference call is scheduled for 4:30 p.m. (Eastern Time) on October 27, 2022.
How can I listen to the DexCom Q3 2022 earnings call?
You can listen to the DexCom Q3 2022 earnings call by dialing (866) 374-5140 for US/Canada or (404) 400-0571 for International callers, using confirmation number 56107665#.
Where can I find the webcast for DexCom's Q3 2022 results?
The webcast for DexCom's Q3 2022 results will be available on their investor relations website at investors.dexcom.com.
